CXL has potential to alter disease course; progression display plays role in when to intervene
Michael W. Belin, MD
Advertisement
Articles by Michael W. Belin, MD
Advertisement
Latest Updated Articles
Keratoconus progression: Looking beyond KmaxPublished: January 16th 2019 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Increasing the knowledge base of GA is key to individualizing patient therapy
2
EYDENZELT, Celltrion’s biosimilar referencing EYLEA, approved by FDA
3
Q&A: Inder Paul Singh, MD, explores technician empowerment via the Academy Technician Training Platform
4
REGENXBIO completes enrollment in ATMOSPHERE and ASCENT trials of sura-vec in wet AMD
5
.png "Optometry Times"){kind=logo}
